FDA Inspection 1102544 — Ningbo Renjian Pharmaceutical Group Co., Ltd.
The FDA completed an inspection of Ningbo Renjian Pharmaceutical Group Co., Ltd. on August 21, 2019 in Weifang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 21, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Weifang (China)